Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 13 Apr 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Antibody Drug Conjugates Contract Manufacturing market size is expected to reach $ 9320.3 million by 2029, rising at a market growth of 18.1% CAGR during the forecast period (2023-2029).

Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.

ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.

This report studies the global Antibody Drug Conjugates Contract Manufacturing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antibody Drug Conjugates Contract Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antibody Drug Conjugates Contract Manufacturing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antibody Drug Conjugates Contract Manufacturing total market, 2018-2029, (USD Million)
Global Antibody Drug Conjugates Contract Manufacturing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antibody Drug Conjugates Contract Manufacturing total market, key domestic companies and share, (USD Million)
Global Antibody Drug Conjugates Contract Manufacturing revenue by player and market share 2018-2023, (USD Million)
Global Antibody Drug Conjugates Contract Manufacturing total market by Type, CAGR, 2018-2029, (USD Million)
Global Antibody Drug Conjugates Contract Manufacturing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Antibody Drug Conjugates Contract Manufacturing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antibody Drug Conjugates Contract Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Antibody Drug Conjugates Contract Manufacturing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation by Type
IgG1
IgG4

Global Antibody Drug Conjugates Contract Manufacturing Market, Segmentation by Application
Solid Tumors
Hematological Malignancies

Companies Profiled:
Lonza Group
Merck KGaA
Recipharm
Thermo Fisher Scientific
Abbvie
Piramal Pharma Solutions
Catalent
Sterling Pharma Solutions
Curia
Novasep
Ajinomoto Bio-Pharma Services
BSP Pharmaceuticals
Cerbios-Pharma
Goodwin Biotechnology

Key Questions Answered
1. How big is the global Antibody Drug Conjugates Contract Manufacturing market?
2. What is the demand of the global Antibody Drug Conjugates Contract Manufacturing market?
3. What is the year over year growth of the global Antibody Drug Conjugates Contract Manufacturing market?
4. What is the total value of the global Antibody Drug Conjugates Contract Manufacturing market?
5. Who are the major players in the global Antibody Drug Conjugates Contract Manufacturing market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antibody Drug Conjugates Contract Manufacturing Introduction
    1.2 World Antibody Drug Conjugates Contract Manufacturing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Antibody Drug Conjugates Contract Manufacturing Total Market by Region (by Headquarter Location)
        1.3.1 World Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.3 China Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.5 Japan Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.6 South Korea Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.7 ASEAN Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
        1.3.8 India Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antibody Drug Conjugates Contract Manufacturing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antibody Drug Conjugates Contract Manufacturing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.2 World Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region
        2.2.1 World Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2023)
        2.2.2 World Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.4 China Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.5 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.6 Japan Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.7 South Korea Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.8 ASEAN Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)
    2.9 India Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029)

3 World Antibody Drug Conjugates Contract Manufacturing Companies Competitive Analysis
    3.1 World Antibody Drug Conjugates Contract Manufacturing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Antibody Drug Conjugates Contract Manufacturing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Antibody Drug Conjugates Contract Manufacturing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Antibody Drug Conjugates Contract Manufacturing in 2022
    3.3 Antibody Drug Conjugates Contract Manufacturing Company Evaluation Quadrant
    3.4 Antibody Drug Conjugates Contract Manufacturing Market: Overall Company Footprint Analysis
        3.4.1 Antibody Drug Conjugates Contract Manufacturing Market: Region Footprint
        3.4.2 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
        3.4.3 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Antibody Drug Conjugates Contract Manufacturing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Antibody Drug Conjugates Contract Manufacturing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Antibody Drug Conjugates Contract Manufacturing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Antibody Drug Conjugates Contract Manufacturing Consumption Value Comparison
        4.2.1 United States VS China: Antibody Drug Conjugates Contract Manufacturing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Antibody Drug Conjugates Contract Manufacturing Companies and Market Share, 2018-2023
        4.3.1 United States Based Antibody Drug Conjugates Contract Manufacturing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023)
    4.4 China Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue and Market Share, 2018-2023
        4.4.1 China Based Antibody Drug Conjugates Contract Manufacturing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023)
    4.5 Rest of World Based Antibody Drug Conjugates Contract Manufacturing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Antibody Drug Conjugates Contract Manufacturing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Antibody Drug Conjugates Contract Manufacturing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 IgG1
        5.2.2 IgG4
    5.3 Market Segment by Type
        5.3.1 World Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
        5.3.2 World Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
        5.3.3 World Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Antibody Drug Conjugates Contract Manufacturing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Solid Tumors
        6.2.2 Hematological Malignancies
    6.3 Market Segment by Application
        6.3.1 World Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
        6.3.2 World Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
        6.3.3 World Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Lonza Group
        7.1.1 Lonza Group Details
        7.1.2 Lonza Group Major Business
        7.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.1.4 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Lonza Group Recent Developments/Updates
        7.1.6 Lonza Group Competitive Strengths & Weaknesses
    7.2 Merck KGaA
        7.2.1 Merck KGaA Details
        7.2.2 Merck KGaA Major Business
        7.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.2.4 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck KGaA Recent Developments/Updates
        7.2.6 Merck KGaA Competitive Strengths & Weaknesses
    7.3 Recipharm
        7.3.1 Recipharm Details
        7.3.2 Recipharm Major Business
        7.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.3.4 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Recipharm Recent Developments/Updates
        7.3.6 Recipharm Competitive Strengths & Weaknesses
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Details
        7.4.2 Thermo Fisher Scientific Major Business
        7.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.4.4 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Thermo Fisher Scientific Recent Developments/Updates
        7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.5 Abbvie
        7.5.1 Abbvie Details
        7.5.2 Abbvie Major Business
        7.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.5.4 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Abbvie Recent Developments/Updates
        7.5.6 Abbvie Competitive Strengths & Weaknesses
    7.6 Piramal Pharma Solutions
        7.6.1 Piramal Pharma Solutions Details
        7.6.2 Piramal Pharma Solutions Major Business
        7.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.6.4 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Piramal Pharma Solutions Recent Developments/Updates
        7.6.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
    7.7 Catalent
        7.7.1 Catalent Details
        7.7.2 Catalent Major Business
        7.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.7.4 Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Catalent Recent Developments/Updates
        7.7.6 Catalent Competitive Strengths & Weaknesses
    7.8 Sterling Pharma Solutions
        7.8.1 Sterling Pharma Solutions Details
        7.8.2 Sterling Pharma Solutions Major Business
        7.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.8.4 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Sterling Pharma Solutions Recent Developments/Updates
        7.8.6 Sterling Pharma Solutions Competitive Strengths & Weaknesses
    7.9 Curia
        7.9.1 Curia Details
        7.9.2 Curia Major Business
        7.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.9.4 Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Curia Recent Developments/Updates
        7.9.6 Curia Competitive Strengths & Weaknesses
    7.10 Novasep
        7.10.1 Novasep Details
        7.10.2 Novasep Major Business
        7.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.10.4 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novasep Recent Developments/Updates
        7.10.6 Novasep Competitive Strengths & Weaknesses
    7.11 Ajinomoto Bio-Pharma Services
        7.11.1 Ajinomoto Bio-Pharma Services Details
        7.11.2 Ajinomoto Bio-Pharma Services Major Business
        7.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.11.4 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Ajinomoto Bio-Pharma Services Recent Developments/Updates
        7.11.6 Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
    7.12 BSP Pharmaceuticals
        7.12.1 BSP Pharmaceuticals Details
        7.12.2 BSP Pharmaceuticals Major Business
        7.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.12.4 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 BSP Pharmaceuticals Recent Developments/Updates
        7.12.6 BSP Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Cerbios-Pharma
        7.13.1 Cerbios-Pharma Details
        7.13.2 Cerbios-Pharma Major Business
        7.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.13.4 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Cerbios-Pharma Recent Developments/Updates
        7.13.6 Cerbios-Pharma Competitive Strengths & Weaknesses
    7.14 Goodwin Biotechnology
        7.14.1 Goodwin Biotechnology Details
        7.14.2 Goodwin Biotechnology Major Business
        7.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Services
        7.14.4 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Goodwin Biotechnology Recent Developments/Updates
        7.14.6 Goodwin Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antibody Drug Conjugates Contract Manufacturing Industry Chain
    8.2 Antibody Drug Conjugates Contract Manufacturing Upstream Analysis
    8.3 Antibody Drug Conjugates Contract Manufacturing Midstream Analysis
    8.4 Antibody Drug Conjugates Contract Manufacturing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Antibody Drug Conjugates Contract Manufacturing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Antibody Drug Conjugates Contract Manufacturing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Antibody Drug Conjugates Contract Manufacturing Players in 2022
    Table 12. World Antibody Drug Conjugates Contract Manufacturing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Antibody Drug Conjugates Contract Manufacturing Company Evaluation Quadrant
    Table 14. Head Office of Key Antibody Drug Conjugates Contract Manufacturing Player
    Table 15. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
    Table 16. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
    Table 17. Antibody Drug Conjugates Contract Manufacturing Mergers & Acquisitions Activity
    Table 18. United States VS China Antibody Drug Conjugates Contract Manufacturing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Antibody Drug Conjugates Contract Manufacturing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Antibody Drug Conjugates Contract Manufacturing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue Market Share (2018-2023)
    Table 23. China Based Antibody Drug Conjugates Contract Manufacturing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Antibody Drug Conjugates Contract Manufacturing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Antibody Drug Conjugates Contract Manufacturing Revenue Market Share (2018-2023)
    Table 29. World Antibody Drug Conjugates Contract Manufacturing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Antibody Drug Conjugates Contract Manufacturing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Lonza Group Basic Information, Area Served and Competitors
    Table 36. Lonza Group Major Business
    Table 37. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 38. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Lonza Group Recent Developments/Updates
    Table 40. Lonza Group Competitive Strengths & Weaknesses
    Table 41. Merck KGaA Basic Information, Area Served and Competitors
    Table 42. Merck KGaA Major Business
    Table 43. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 44. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Merck KGaA Recent Developments/Updates
    Table 46. Merck KGaA Competitive Strengths & Weaknesses
    Table 47. Recipharm Basic Information, Area Served and Competitors
    Table 48. Recipharm Major Business
    Table 49. Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 50. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Recipharm Recent Developments/Updates
    Table 52. Recipharm Competitive Strengths & Weaknesses
    Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 54. Thermo Fisher Scientific Major Business
    Table 55. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 56. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Thermo Fisher Scientific Recent Developments/Updates
    Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 59. Abbvie Basic Information, Area Served and Competitors
    Table 60. Abbvie Major Business
    Table 61. Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 62. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Abbvie Recent Developments/Updates
    Table 64. Abbvie Competitive Strengths & Weaknesses
    Table 65. Piramal Pharma Solutions Basic Information, Area Served and Competitors
    Table 66. Piramal Pharma Solutions Major Business
    Table 67. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 68. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Piramal Pharma Solutions Recent Developments/Updates
    Table 70. Piramal Pharma Solutions Competitive Strengths & Weaknesses
    Table 71. Catalent Basic Information, Area Served and Competitors
    Table 72. Catalent Major Business
    Table 73. Catalent Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 74. Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Catalent Recent Developments/Updates
    Table 76. Catalent Competitive Strengths & Weaknesses
    Table 77. Sterling Pharma Solutions Basic Information, Area Served and Competitors
    Table 78. Sterling Pharma Solutions Major Business
    Table 79. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 80. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Sterling Pharma Solutions Recent Developments/Updates
    Table 82. Sterling Pharma Solutions Competitive Strengths & Weaknesses
    Table 83. Curia Basic Information, Area Served and Competitors
    Table 84. Curia Major Business
    Table 85. Curia Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 86. Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Curia Recent Developments/Updates
    Table 88. Curia Competitive Strengths & Weaknesses
    Table 89. Novasep Basic Information, Area Served and Competitors
    Table 90. Novasep Major Business
    Table 91. Novasep Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 92. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Novasep Recent Developments/Updates
    Table 94. Novasep Competitive Strengths & Weaknesses
    Table 95. Ajinomoto Bio-Pharma Services Basic Information, Area Served and Competitors
    Table 96. Ajinomoto Bio-Pharma Services Major Business
    Table 97. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 98. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Ajinomoto Bio-Pharma Services Recent Developments/Updates
    Table 100. Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
    Table 101. BSP Pharmaceuticals Basic Information, Area Served and Competitors
    Table 102. BSP Pharmaceuticals Major Business
    Table 103. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 104. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. BSP Pharmaceuticals Recent Developments/Updates
    Table 106. BSP Pharmaceuticals Competitive Strengths & Weaknesses
    Table 107. Cerbios-Pharma Basic Information, Area Served and Competitors
    Table 108. Cerbios-Pharma Major Business
    Table 109. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 110. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Cerbios-Pharma Recent Developments/Updates
    Table 112. Goodwin Biotechnology Basic Information, Area Served and Competitors
    Table 113. Goodwin Biotechnology Major Business
    Table 114. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Services
    Table 115. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Antibody Drug Conjugates Contract Manufacturing Upstream (Raw Materials)
    Table 117. Antibody Drug Conjugates Contract Manufacturing Typical Customers
List of Figure
    Figure 1. Antibody Drug Conjugates Contract Manufacturing Picture
    Figure 2. World Antibody Drug Conjugates Contract Manufacturing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Antibody Drug Conjugates Contract Manufacturing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Antibody Drug Conjugates Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 13. Antibody Drug Conjugates Contract Manufacturing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Antibody Drug Conjugates Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Antibody Drug Conjugates Contract Manufacturing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Antibody Drug Conjugates Contract Manufacturing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Antibody Drug Conjugates Contract Manufacturing Markets in 2022
    Figure 27. United States VS China: Antibody Drug Conjugates Contract Manufacturing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Antibody Drug Conjugates Contract Manufacturing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type in 2022
    Figure 31. IgG1
    Figure 32. IgG4
    Figure 33. World Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2018-2029)
    Figure 34. World Antibody Drug Conjugates Contract Manufacturing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2022
    Figure 36. Solid Tumors
    Figure 37. Hematological Malignancies
    Figure 38. Antibody Drug Conjugates Contract Manufacturing Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Antibody Drug Conjugates Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Antibody Drug Conjugates Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 13 Apr 2023

date Medical Care

According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2022 and is forecast to a readjusted size of USD 9320.3 million by 2029 with a CAGR of 18.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Antibody Drug Conjugates Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antibody Drug Conjugates Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2023 and is forecast to a readjusted size of USD 9320.3 million by 2030 with a CAGR of 18.1% during review period.

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

Global Antibody Drug Conjugates Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

date 02 Apr 2024

date Medical Care

The global Antibody Drug Conjugates Contract Manufacturing market size is expected to reach $ 9320.3 million by 2030, rising at a market growth of 18.1% CAGR during the forecast period (2024-2030).

Product Tags

Antibody Drug Conjugates Contract Manufacturing

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>